Your browser doesn't support javascript.
loading
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Southey, Melissa C; Goldgar, David E; Winqvist, Robert; Pylkäs, Katri; Couch, Fergus; Tischkowitz, Marc; Foulkes, William D; Dennis, Joe; Michailidou, Kyriaki; van Rensburg, Elizabeth J; Heikkinen, Tuomas; Nevanlinna, Heli; Hopper, John L; Dörk, Thilo; Claes, Kathleen Bm; Reis-Filho, Jorge; Teo, Zhi Ling; Radice, Paolo; Catucci, Irene; Peterlongo, Paolo; Tsimiklis, Helen; Odefrey, Fabrice A; Dowty, James G; Schmidt, Marjanka K; Broeks, Annegien; Hogervorst, Frans B; Verhoef, Senno; Carpenter, Jane; Clarke, Christine; Scott, Rodney J; Fasching, Peter A; Haeberle, Lothar; Ekici, Arif B; Beckmann, Matthias W; Peto, Julian; Dos-Santos-Silva, Isabel; Fletcher, Olivia; Johnson, Nichola; Bolla, Manjeet K; Sawyer, Elinor J; Tomlinson, Ian; Kerin, Michael J; Miller, Nicola; Marme, Federik; Burwinkel, Barbara; Yang, Rongxi; Guénel, Pascal; Truong, Thérèse; Menegaux, Florence; Sanchez, Marie.
Affiliation
  • Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Goldgar DE; Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, University of Oulu, Nordlab Oulu, Oulu, Finland.
  • Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, University of Oulu, Nordlab Oulu, Oulu, Finland.
  • Couch F; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Tischkowitz M; Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, and the Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrooke's Hospital.
  • Foulkes WD; Program in Cancer Genetics, Department of Human Genetics and Oncology, Lady Davis Institute, and Research Institute, McGill University Health Centre, McGill University, Montreal, Canada.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
  • Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
  • van Rensburg EJ; Department of Genetics, University of Pretoria, South Africa.
  • Heikkinen T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  • Claes KB; Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.
  • Reis-Filho J; Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Teo ZL; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
  • Catucci I; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Peterlongo P; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
  • Tsimiklis H; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Odefrey FA; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
  • Dowty JG; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Hogervorst FB; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Verhoef S; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Carpenter J; Australian Breast Cancer Tissue Bank, University of Sydney at the Westmead Institute for Medical Research, NSW, Australia.
  • Clarke C; Centre for Cancer Research, University of Sydney at the Westmead Institute for Medical Research, NSW, Australia.
  • Scott RJ; Division of Molecular Medicine, Pathology North, Newcastle and University of Newcastle, NSW, Australia.
  • Fasching PA; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Haeberle L; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, CA, USA.
  • Ekici AB; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Beckmann MW; Unit of Biostatistics, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Peto J; Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Dos-Santos-Silva I; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Fletcher O; Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
  • Johnson N; Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
  • Bolla MK; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Sawyer EJ; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
  • Tomlinson I; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
  • Kerin MJ; Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, UK.
  • Miller N; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, UK and Oxford NIHR Biomedical Research Centre, Headington, OX3 7LE.
  • Marme F; Surgery, Lambe Institute for Translational Science, NUIGalway, University Hospital Galway, Galway, Ireland.
  • Burwinkel B; Surgery, Lambe Institute for Translational Science, NUIGalway, University Hospital Galway, Galway, Ireland.
  • Yang R; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Guénel P; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Truong T; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Menegaux F; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sanchez M; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
J Med Genet ; 53(12): 800-811, 2016 12.
Article in En | MEDLINE | ID: mdl-27595995
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Nuclear Proteins / Genetic Predisposition to Disease / Tumor Suppressor Proteins / Ataxia Telangiectasia Mutated Proteins / Checkpoint Kinase 2 / Mutation Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Med Genet Year: 2016 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Nuclear Proteins / Genetic Predisposition to Disease / Tumor Suppressor Proteins / Ataxia Telangiectasia Mutated Proteins / Checkpoint Kinase 2 / Mutation Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Med Genet Year: 2016 Type: Article Affiliation country: Australia